What's new

Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised

Feb 20, 2025 - 13:18
 0
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Sapropterin Dipharma, sapropterin, Date of authorisation: 16/02/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Giles Kinnersley joins AMPECO as Business Development Director for the UK and Ir...

Next Article

India advises co-location of energy storage with solar PV

Related Posts

Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Herbal medicinal product: Pilosellae herba cum radiceArray, F: Assessment finalised

Herbal medicinal product: Pilosellae herba cum radiceAr...

Feb 26, 2025  0

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0